3/13/2026

Acetylcysteine Intravenous Solution

Products Affected - Description

- Acetylcysteine intravenous solution for injection, Eugia US, 200 mg/mL, 30 mL vial, 4 count, NDC 55150-0259-30
- Acetylcysteine intravenous solution for injection, Fresenius Kabi, 200 mg/mL, 30 mL vial, NDC 63323-0963-30
- Acetylcysteine intravenous solution for injection, Glenmark, 200 mg/mL, 30 mL vial, 4 count, NDC 68462-0946-12
- Acetylcysteine intravenous solution for injection, Glenmark, 200 mg/mL, 30 mL vial, NDC 68462-0946-30
- Acetylcysteine intravenous solution for injection, Hikma, 200 mg/mL, 30 mL vial, 4 count, NDC 70594-0111-02
- Acetylcysteine intravenous solution for injection, Hikma, 200 mg/mL, 30 mL vial, NDC 70594-0111-01
- Acetylcysteine intravenous solution for injection, Padagis, 200 mg/mL, 30 mL vial, NDC 00574-0815-00
- Acetylcysteine intravenous solution for injection, Sagent, 200 mg/mL, 30 mL vial, 4 count, NDC 25021-812-30

Reason for the Shortage

- Cumberland has Acetadote available.
- Eugia did not provide a reason for the shortage.
- Fresenius Kabi did not provide a reason for the shortage.
- Glenmark did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.
- Padagis did not provide a reason for the shortage.
- Sagent did not provide a reason for the shortage.
- Somerset has acetylcysteine intravenous solution available.

Available Products

- Acetadote intravenous solution for injection, Cumberland Pharmaceuticals, 200 mg/mL, 30 mL vial, NDC 66220-0207-30
- Acetylcysteine intravenous solution for injection, Somerset Therapeutics LLC, 200 mg/mL, 30 mL vial, 4 count, NDC 70069-0788-04
- Acetylcysteine intravenous solution for injection, Somerset Therapeutics LLC, 200 mg/mL, 30 mL vial, NDC 70069-0788-01

Estimated Resupply Dates

- Eugia has acetylcysteine 30 mL vials in 4-count packages on back order and the company estimates a release date of April 2026.
- Freseniu Kabi has acetylcysteine 30 mL vials on back order and the company estimates a release date of late-April 2026.
- Glenmark Pharmaceuticals has acetylcysteine 30 mL vials in single-count and 4-count packages on back order and the company estimates a release date of July 2026.
- Hikma has acetylcysteine 30 mL vials in single-count and 4-count packages on back order and the company estimates a release date of late-March 2026.
- Padagis has acetylcysteine 30 mL vials on back order and the company estimates a release date of March 2026.
- Sagent has acetylcysteine 30 mL vials in 4-count packages on back order and the company estimates a release date of March 2026.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.